• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Physiological role of a presynaptic protein, NACP : Involvement in signal transduction systems

Research Project

Project/Area Number 09680780
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Neurochemistry/Neuropharmacology
Research InstitutionTokyo Institute of Psychiatry

Principal Investigator

UEDA Kenji  Tokyo Institute of Psychiatry, Department of Neurochemistry, Senior Research Scientist, 神経化学研究部門, 主任研究員 (90261180)

Co-Investigator(Kenkyū-buntansha) NUKADA Toshihide  Tokyo Institute of Psychiatry, Department of Neurochemistry, Principle Research, 神経化学研究部門, 副参事研究員 (80189349)
Project Period (FY) 1997 – 1998
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥3,300,000 (Direct Cost: ¥3,300,000)
Fiscal Year 1998: ¥1,500,000 (Direct Cost: ¥1,500,000)
Fiscal Year 1997: ¥1,800,000 (Direct Cost: ¥1,800,000)
KeywordsNAC / NACP / Alzheimer / Parkinson / synuclein / signal transduction / neuronal degeneration
Research Abstract

We found a novel component of Alzheimer's disease (AD) amyloid, named NAC (non-Abeta component of AD amyloid) and cloned cDNA encoding NAC precursor protein, NACP.It should be noted in particular that expression pattern for NACP mirrors the distribution of typical AD pathology. The number of plaques does not necessarily correspond to the severity of cognitive impairment, while there is a strong correlation between the extent of synapse loss and the impairment. NACP is a presynaptic protein, and, therefore, some alterations of NACP including mutations could influence synaptic functions, leading to symptoms like dementia. We showed that NACP is aberrantly expressed not only in synaptic region, but also in dystrophic neurites in AD brain.
Recently, two kinds of missense mutations in the NACP gene segregating the illness were found in five independent familial Parkinson's disease (PD) pedigrees. We showed that the filamentous components of Lewy bodies, aneuropathological hallmark of PD and … More of dementia with Lewy bodies (DLB) include entire molecule of NACP by immunoelectron microscopy. It was reported that recombinant NACP forms fibrils in vitro like Lewy bodies and the fibril formation is accelerated with those mutations. Thus, it is likely that the accumulation of abnormal filaments of NACP within neurons, axons, and presynaptic regions could interfere the function of neuron, i.e., neurotransmission, leading to Parkinsonisms and dementia as symptoms, and to neuronal cell death eventually. In fact, we showed that the degenerative teiminal axons of the perforant pathway in the hippocampus with DLB contain NACP-positive abnormal structures, while the origin cells of those axons contain only a few Lewy bodies, suggesting a 'dying back' degenerating process due to a blockage of axonal transport. We also revealed that not only argyrophilic glial inclusions in PD/DLB are NACP-positive, but also cytoplasmic inclusions of multiple system atrophy contain the whole NACP molecule. These findings suggest that the alteration of NACP may be involved primarily in the pathogenesis of several different neurodegenerative diseases. Less

Report

(3 results)
  • 1998 Annual Research Report   Final Research Report Summary
  • 1997 Annual Research Report
  • Research Products

    (23 results)

All Other

All Publications (23 results)

  • [Publications] Ishimaru,H.et al.: "Changes in presynaptic protein NACP/α-synuclein in an ischemic gerbil hippocampus." Brain Research. 788. 311-314 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Arima,K.et al.: "Immunoelectron microscopic demonstration of NACP/α-synuclein epitopes on the filamentous component of lewy bodies in Parkinson's disease and dementia with Lewy bodies" Brain Rersearch. 808. 93-100 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Arima,K.et al.: "NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy" Acta Neuropathologica. 96. 439-444 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Iseki,E.et al.: "Degenerative terminals of the perforant pathway are human α-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease" Neuroscience Letterrs. 258. 81-84 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Arai,T.et al.: "Argyrophilic glial inclusions in the midbrain of patients with Parkinson's disease and diffuse Lewy body disease are immunopositive for NACP/α-synuclein." Neuroscience Letters. 259. 83-86 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Iseki,E.et al.: "Frequen coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease" Neuroscience Letterrs. (in press). (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] 上田健治: "アルツハイマー病脳から同定され、パーキンソン病原因遺伝子であったNACP/α-synuclein." 日本薬理学雑誌. 113. 121 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] E.Iseki et al.: "Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease." Nurosci.Lett.(in press). (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] T.Arai et al.: "Argyrophilic glial inclusions in the midbrain of patients with Parkinson's disease and diffuse Lewy body disease are immunopositive for NACP/alpha-synuclein" Neurosci.Lett.259. 83-86 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] E.Iseki et al.: "Degenerative terminals of the perforant pathway are human alpha-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease" Neurosci.Lett.258. 81-84 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] K.Arima et al.: "NACP/alpha-synuclein-immunoreactive in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy" Acta Neuropathol.96. 439-444 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] K.Arima et al.: "Immunoelectron microscopic demonstration of NACP/alpha-synuclein epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies" Brain Res.808. 93-100 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] H.Ishimaru et al.: "Changes in presynaptic protein NACP/alpha-synuclein in an ischemic gerbil hippocampus." Brain Res.788. 311-314 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] K.UEDA: "NACP/alpha-synuclein, originally found in Alzheimer's disease brain is a causal gene for Parkinson's disease" Folia Pharmacol.Jpn.113. 121 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Arima,K.et al.: "Immunoelectron microscopic demonstration of NACP/α-synuclein epitopes on the filamentous component of Lewy bodies in Parkinson's disease and dementia with Lew bodies" Brain Research. 808. 93-100 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Arima,K.et al.: "NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy" Acta Neuropathologica. 96. 439-444 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Iseki,E.et al.: "Degenerative terminals of the perforant pathway are human α-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease" Neuroscience Letters. 258. 81-84 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Arai,T.et al.: "Argyrophilic glial inclusions in the midbrain of patients with Parkinson's disease and diffuse Lewy body disease are immunopositive for NACP/α-synuclein." Neuroscience Letters. 259. 83-86 (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] Iseki,E.et al.: "Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease" Neuroscience Letters. (in press). (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] 上田健治: "アルツハイマー病脳から同定され、パーキンソン病原因遺伝子であったNACP/α-synuclein." 日本薬理学雑誌. (印刷中). (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] Ishimaru H, Ueda K,Takahashi A & Mruyama y: "Changes in presynaptic protein NACP/a-synuclein in an ischemic gerbil hippocampus" Brain Research. (in press). (1998)

    • Related Report
      1997 Annual Research Report
  • [Publications] 上田 健治: "パーキンソン病とアルツハイマー病に共通機構の可能性:鍵タンパク質NACP/α-シヌクレイン" 細胞工学. 16(12). 2-3 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] 上田 健治: "アルツハイマー病におけるNACアミロイドとNACP" Dementia Japan. 11(1). 61-75 (1997)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1997-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi